Chronic Lymphocytic Leukemia

About
Mappings

OncoTree: Chronic Lymphocytic Leukemia (ncit:C3163)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
FDA (1) CD20 + Chronic Lymphocytic Leukemia Cyclophosphamide, Fludarabine, Rituximab
EMA (1) HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Venetoclax
EMA (2) HSE (1) 17p deletion Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) Wild type TP53 Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) 17p deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) 17p deletion Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) 17p deletion Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Ibrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Ibrutinib
FDA (1) HSE (1) 17p deletion Chronic Lymphocytic Leukemia Ibrutinib